Drug
Tazemetostat And 14c Tazemetostat
Tazemetostat And 14c Tazemetostat: highest development phase Phase 1, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tazemetostat and [14C] Tazemetostat NCT03010982 | Phase 1 | Diffuse Large B Cell Lymphoma |
Latest
No recent events.
Follow Tazemetostat And 14c Tazemetostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.